MDT · Medtronic plc
$80.982026-07-21Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$81
-0.4% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($43 · $88) Analysts Range ($80 · $119) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q4 | $32.4B | — | 17.5% | 23.4% | $4.3B | −$262MM | $4.1B | 6.7% | — | 5.8% | $75.2B | $2.85 | — |
| 2025.Q3 | $33.5B | 3.6% | 19.6% | 17.9% | $5.4B | $1.4B | $6.8B | 7.9% | — | 7.1% | $76.1B | $3.62 | — |
| 2025.Q4 | $33.5B | 0.0% | 19.6% | 16.6% | $5.5B | $1.2B | $6.7B | 7.0% | — | 7.2% | $75.6B | $3.62 | — |
| 2026.Q3 | $36.4B | 8.4% | 19.6% | 16.6% | $5.9B | −$778MM | $5.2B | 7.4% | — | 7.8% | $77.1B | $3.73 | — |
| 2026.Q4 | $36.4B | 0.0% | 19.6% | 21.2% | $5.6B | −$1.4B | $4.2B | 6.7% | — | 7.3% | $76.6B | $3.73 | 14.6 |
| italics below = DCF projection · 10yr Rev CAGR: 5.6% |
| 2027.Q4 | $38.9B | +7.0% | 19.7% | 21.1% | $6.1B | −$677MM | $5.4B | 7.7% | $5.0B | 7.9% | $77.3B | $4.27 | 19.0 |
| 2028.Q4 | $41.5B | +6.7% | 20.6% | 20.9% | $6.8B | −$975MM | $5.8B | 7.8% | $5.0B | 8.7% | $78.3B | $4.78 | 16.9 |
| 2029.Q4 | $44.2B | +6.4% | 20.9% | 20.8% | $7.3B | −$1.7B | $5.6B | 7.9% | $4.5B | 9.2% | $79.9B | $5.15 | 15.7 |
| 2030.Q4 | $46.9B | +6.1% | 22.2% | 20.7% | $8.3B | −$1.4B | $6.9B | 8.0% | $5.1B | 10.2% | $81.3B | $5.82 | 13.9 |
| 2031.Q4 | $49.6B | +5.7% | 22.2% | 20.6% | $8.7B | −$1.6B | $7.2B | 8.1% | $4.9B | 10.6% | $82.9B | $6.16 | 13.1 |
|
| Term. Yr+ | $65.1B | 4.1% | 19.6% | 20.0% | $10.2B | −$3.2B | $7.0B | 8.6% | $71.2B | 13.1% | — | — | — |
Active scenario IV: $81 (-0.4% vs market)